Treatment for severe obesity has developed rapidly in recent years.
Now, new research findings from pharmaceutical company Eli Lilly suggest that a new drug may be even more effective than existing alternatives, according to Nieuwsblad.
The drug is called retatrutide and belongs to the same class of medications as Ozempic and Mounjaro.
The difference is that retatrutide targets three hormone receptors, while most similar drugs affect one or two.
Also read: Laura Dern shares the most important lesson she learned from her mother’s battle with illness
Experts see potential
According to endocrinologist Imke Matthys of UZ Gent, having several different types of medication available can be beneficial.
Some patients do not achieve sufficient results with existing treatments, while others experience side effects.
That is why it is important to have multiple options available, she told Nieuwsblad.
However, Professor Chantal Mathieu of KU Leuven believes that very rapid weight loss is not necessarily the best solution.
Also read: These common mouth changes could be darly warning signs of oral cancer
She points out that sustainable weight loss often takes time.
Illegal sales raise concerns
Although retatrutide is not yet available on the general market, it is already being sold online and discussed on various internet forums. This concerns experts.
Toxicologist Jan Tytgat warns that consumers cannot be certain of the contents of illegally sold medication.
Previous investigations of similar products have revealed problems with both dosage and quality.
Also read: New study: Ham, sausages and snacks linked to increased dementia risk
The manufacturer's trial, which included 2,339 participants over 80 weeks, produced striking results.
Participants lost an average of 32 kilograms, equivalent to 28 percent of their body weight.
According to Eli Lilly, retatrutide could therefore become the most effective weight-loss drug to date if the findings are confirmed through peer review.
Source: Nieuwsblad.
Also read: Researchers track men for 32 years and find health risks associated with snus
Also read: Trump’s trousers spark online speculation after memorial day ceremony
This article is made and published by Ida-Marie Palm Varbæk, who may have used AI in the preparation.